- POSITIVE
Quarterly Revenue Jyothy Labs Jun-2026 Quarterly Revenue is Rs 791 Cr which is growth of 2.6% YoY.
- NEGATIVE
Quarterly Net Profit Jyothy Labs Jun-2026 Quarterly Net Profit is Rs 48 Cr which is growth of -50.8% YoY.
Jyothy Labs Live Share Price Today, Share Analysis and Chart
NSE 30 Oct, 2026 3:31 PM (IST)
Jyothy Labs Stock Price Analysis
Day Price Range-1.8% 1 Day return | 171.9 (LTP) 171175.1 LowHigh |
|---|---|
Week Price Range-2.0% 1 Week return | 171.9 (LTP) 171176.2 LowHigh |
Month Price Range-6.7% 1 Month return | 171.9 (LTP) 171195.9 LowHigh |
52 Week Price Range-46.3% 1 Year return | 171.9 (LTP) 171319.9 LowHigh |
Jyothy Labs Forecaster - Analyst Share Price Target and Estimates
Revenue forecast
EPS forecast
Consensus Recommendation
Jyothy Labs quarterly results: revenue, profit, and P&L – 13 quarter history
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 791.1 | 733.2 | 755 | 753 | 770.7 | 681.4 | 717.5 | 745.6 | 754.9 | 672.2 | 687.4 | 744.8 | 703.3 | ||
Operating Exp. | 708.7 | 620.7 | 628.9 | 617.8 | 627.1 | 553.8 | 587.9 | 594.7 | 607.6 | 550.8 | 558.2 | 596.2 | 568.9 | |
Operating Profit | 64.7 | 96.8 | 110.7 | 118.3 | 124.2 | 112.1 | 115.8 | 138.3 | 133.6 | 108.4 | 118.6 | 135.4 | 117.5 | |
Operating Profit Margin % | 8.36% | 13.49% | 14.97% | 16.07% | 16.53% | 16.84% | 16.45% | 18.87% | 18.03% | 16.45% | 17.53% | 18.50% | 17.12% | |
Depr. | 16.2 | 15.8 | 15.5 | 15.2 | 14.7 | 14.6 | 14.3 | 13.9 | 13.4 | 12.9 | 12.8 | 12.3 | 12 | |
Interest | 1.2 | 1.2 | 1.1 | 1.4 | 1.3 | 1.7 | 1.5 | 1.4 | 1.4 | 1.3 | 1.2 | 1.2 | 1.1 | |
Profit Before Tax | 65 | 95.5 | 109.5 | 118.7 | 127.5 | 107.6 | 113.8 | 135.6 | 132.5 | 107.3 | 115.2 | 135.1 | 121.4 | |
Tax | 17.3 | 28 | 28.3 | 30.9 | 30.7 | 30.6 | 26.4 | 30.7 | 30.7 | 29.1 | 24.3 | 30.7 | 25 | |
Net Profit | 47.6 | 67.5 | 81.1 | 87.8 | 96.8 | 77 | 87.4 | 104.9 | 101.8 | 78.2 | 90.9 | 104.4 | 96.4 | |
EPS Adj. latest | 1.3 | 1.8 | 2.2 | 2.4 | 2.6 | 2.1 | 2.4 | 2.9 | 2.8 | 2.1 | 2.5 | 2.8 | 2.6 | |
Net profit TTM | 284 | 333.2 | 342.7 | 349 | 366.1 | 371.2 | 372.4 | 375.9 | 375.4 | 369.9 | 350.7 | 321.5 | 286.4 | |
Basic EPS TTM | 7.7 | 9.1 | 9.3 | 9.5 | 10 | 10.1 | 10.1 | 10.2 | 10.2 | 10.1 | 9.6 | 8.8 | 7.8 | |
Earnings Transcripts | ||||||||||||||
AI Summary | ||||||||||||||
Results PDF | ||||||||||||||
Result Notes |
Jyothy Labs Technical Analysis
Jyothy Labs EMA & SMA
| 5 Day | 174.5 |
|---|---|
| 10 Day | 177.5 |
| 12 Day | 178.5 |
| 20 Day | 181.8 |
| 26 Day | 183.8 |
|---|---|
| 50 Day | 189.5 |
| 100 Day | 199.0 |
| 200 Day | 221.6 |
Jyothy Labs Delivery And Volume
Jyothy Labs Resistance and Support
| First Resistance | 174.3 |
|---|---|
| Second Resistance | 176.8 |
| Third Resistance | 178.4 |
| First Support | 170.2 |
|---|---|
| Second Support | 168.6 |
| Third Support | 166.1 |
| Day RSI | 29.8 |
|---|---|
| Day MACD | -5.2 |
| Day MFI | 36.7 |
| Day MACD Signal Line | -4.2 |
Jyothy Labs Beta
| 1 Month | 0.4 |
|---|---|
| 1 Year | 1.0 |
| 3 Month | 0.6 |
|---|---|
| 3 Year | 0.7 |
Jyothy Labs Price Change Analysis
Jyothy Labs Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 09 Apr 2025 | 372.61 | 2,071,772 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 09 Apr 2025 | 372.47 | 2,071,772 | NSE |
| SOCIETE GENERALE | Block | Sell | 25 Jan 2024 | 535.95 | 328,141 | NSE |
| MARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND | Block | Purchase | 25 Jan 2024 | 535.95 | 328,141 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 26 Jul 2023 | 310.07 | 2,632,739 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | Bulk | Purchase | 26 Jul 2023 | 309.89 | 2,632,739 | NSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | Block | Sell | 11 Oct 2022 | 200.80 | 540,288 | BSE |
| ISHARES INDIA SC MAURITIUS COMPANY | Block | Sell | 11 Oct 2022 | 200.80 | 64,652 | BSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | Block | Purchase | 11 Oct 2022 | 200.80 | 540,288 | BSE |
| ISHARES MSCI INDIA SMALL-CAP ETF | Block | Purchase | 11 Oct 2022 | 200.80 | 64,652 | BSE |
Jyothy Labs Corporate Actions
Jyothy Labs Dividend history and yield
Jyothy Labs dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Jyothy Labs dividend yield over time.
#Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
129 Jun 2026 | 3.5 | FINAL | 29 Jun 2026 | Equity Share |
228 Aug 2025 | 3.5 | FINAL | 28 Aug 2025 | Equity Share |
303 Jul 2024 | 3.5 | FINAL | - | Equity Share |
403 Jul 2023 | 3 | FINAL | - | Equity Share |
501 Jul 2022 | 2.5 | FINAL | - | Equity Share |
Jyothy Labs Bonus shares
Jyothy Labs bonus history along with announcement, record, ex-bonus dates, and bonus ratios.
#Ex-Date | Bonus Ratio | Record Date |
|---|---|---|
128 Jun 2018 | 1:1 | 30 Jun 2018 |
212 Jul 2012 | 1:1 | - |
Jyothy Labs Board Meetings
Jyothy Labs past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
104 Nov 2026 | Quarterly Results | - |
212 Aug 2026 | Quarterly Results | - |
304 May 2026 | Audited Results & Final Dividend | - |
409 Feb 2026 | Quarterly Results | - |
512 Nov 2025 | Quarterly Results | - |
Jyothy Labs Stock Split
Jyothy Labs stock split details, including announcement, record, and ex-split dates, along with the split ratios
#Ex-Date | Old FV | New FV | Record Date |
|---|---|---|---|
112 Dec 2008 | 5 | 1 | 19 Dec 2008 |
Jyothy Labs Research Reports
Jyothy Labs research reports with share price targets, and buy/hold/sell recommendations from top brokers.
# Date | Broker Name | Target | Price When Recommended | Type | Upside | Change Since Recommendation | Links |
|---|---|---|---|---|---|---|---|
| 112 Aug 2026 | BP Wealth | - | 199.98 | Results Update | - | -14.04% | |
| 211 Aug 2026 | Motilal Oswal | 210 | 200.27 | Neutral | 4.86% | -14.16% | |
| 308 Jun 2026 | Geojit BNP Paribas | 239 | 199.47 | Buy | 19.82% | -13.82% | |
| 404 May 2026 | Axis Direct Target | 280 | 265.25 | Hold | 5.56% | -35.19% | |
| 504 May 2026 | BP Wealth | - | 265.25 | Results Update | - | -35.19% |
Jyothy Labs Corporate Filings
Jyothy Labs BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 30 Oct 2026 | Jyothy Labs Ltd - 532926 - Update on board meeting | Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Update on board meeting - Proposed Buyback of Equity Shares | |
| 14 Oct 2026 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | Earnings conference call for quarter and half year ended September 30, 2026. | |
| 13 Oct 2026 | Jyothy Labs Ltd - 532926 - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2026 | Jyothy Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve Board Meeting intimation for Considering And Approving The Un-Audited Financial Results For The Quarter and half year ended September 30, 2026 | |
| 08 Oct 2026 | Jyothy Labs Ltd - 532926 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Compliance certificate under Regulation 74(5) od SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026 | |
| 05 Oct 2026 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | Allotment of Equity Shares pursuant to exercise of Restricted Stock Units under ESOP. |
Jyothy Labs Documents
Jyothy Labs Earnings Call
Jyothy Labs earnings calls, including management commentary and AI-generated summaries.
| Date | Title | Links |
|---|---|---|
| 14 Aug 2026 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 18 Jun 2026 | Jyothy Labs Business Update Call | AudioVideo |
| 07 May 2026 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 13 Feb 2026 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
| 15 Nov 2025 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | Link |
Jyothy Labs Annual Reports
Jyothy Labs financials, including annual results, balance sheets, and cash flow statements.
Jyothy Labs Credit Ratings
Jyothy Labs credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.
| Date | Rating Agency | Company Name | Description | Links |
|---|---|---|---|---|
| 22 Sep 2026 | care ratings | Jyothy Labs Limited | Link | |
| 15 Sep 2025 | care ratings | Jyothy Labs Limited | Link | |
| 14 Apr 2025 | icra ratings | Jyothy Labs Limited | Ratings withdrawn | Link |
| 19 Aug 2024 | care ratings | Jyothy Labs Limited | Link | |
| 03 Apr 2024 | icra ratings | Jyothy Labs Limited | Ratings reaffirmed | Link |
Jyothy Labs Investor Presentations
Jyothy Labs investor presentations, including business updates, financial insights, and strategic initiatives.
| Date | Report Title | Links |
|---|---|---|
| 12 Aug 2026 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 12 Aug 2026 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 04 May 2026 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 09 Feb 2026 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
| 12 Nov 2025 | Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation | Link |
Jyothy Labs - Company Profile
Jyothy Labs Management Structure
Jyothy Labs management structure with salaries, total experience, and qualifications.
Jyothy Labs Board of Directors
Jyothy Labs Board of directors with salaries, total experience, and qualifications.
About the company - Business Profile
Jyothy Labs Limited is a prominent Indian Fast-Moving Consumer Goods (FMCG) company with a significant presence in Home Care and Personal Care. Founded in 1983 as a single-product entity in Kerala, the company has evolved into a multi-brand national player. It maintains a leadership position in the fabric whitener category and holds strong market rankings in dishwashing and household insecticides. The company operates through an extensive distribution network of 1.4 million direct-reach outlets and 23 manufacturing facilities across India.
Key Points
Key Facts
- Founded Year: 1983.
- Headquarters: Mumbai, Maharashtra.
- Stock Listing: BSE and NSE.
- Key Brands: Ujala, Exo, Henko, Pril, Margo, and Maxo.
Operations and Resources
- Manufacturing: Operates 23 manufacturing plants across various locations in India to ensure regional supply chain efficiency.
- Distribution: Products are available in 4 million outlets pan-India, with a direct reach expanding to 1.4 million outlets as of FY 2025-26.
- Infrastructure: Utilizes a network of over 10,000 channel partners to support its go-to-market strategy.
Market and Significance
- Market Rankings: #1 in Fabric Whitener (Ujala Supreme) for four decades; #2 in Dishwash (Exo and Pril) by value; and #2 in Mosquito Repellent Coils (Maxo) by volume.
- Strategic Focus: The company focuses on the Home Care and Personal Care segments, which together constitute approximately 50% of the Indian FMCG industry.
Business Model and Segment Performance Jyothy Labs follows a brand-led business model, focusing on product innovation, distribution expansion, and multi-tier pricing. It is particularly effective at maintaining market share in legacy categories while scaling new formats like liquid detergents.
Revenue Breakdown (FY 2025-26 - Consolidated)
- Total Revenue: Rs 2,944 crore.
- Segment Revenue Share:
- Fabric Care: 45% (Combined Main Wash 36% and Post Wash 9% as of Q4 FY26).
- Dishwashing: 31%.
- Personal Care: 10%.
- Household Insecticides: 10%.
- Others: 4%.
Key Products and Technology Advancements
- Fabric Care: Includes Ujala Supreme (whitener), Henko (premium detergent), and Ujala IDD (detergent). A significant advancement includes scaling Liquid Detergents, which grew nearly 2X in the latest fiscal year.
- Dishwashing: Key brands are Exo (anti-bacterial focus) and Pril (high-grease-cutting efficacy).
- Personal Care: Centered on the Margo brand, leveraging its 100+ year neem heritage. Recent initiatives include a refreshed Margo pack and expansion into new personal care formats.
- Household Insecticides: Managed under the Maxo brand, focusing on Liquid Vaporizers (LV) and traditional coils.
Financial and Human Capital
- Employee Count: Over 8,000 employees.
- Training: Emphasizes capacity building with an average of 2 man-days of training per employee, including programs like Unnati.
- Operating Performance (FY 2025-26):
- Operating EBITDA: Rs 450 crore.
- PAT: Rs 333 crore.
- Operating EBITDA Margin: 15.3%.
- Cash Position: Rs 997 crore (including FDs and Mutual Funds).
- Working Capital: Maintained at 15 days as of March 2026.
Strategic Initiatives and Future Outlook The company is aggressively targeting growth through organized channels, with Modern Trade, E-commerce, and Quick Commerce growing by 26% in the recent period. Strategic focus for FY 2026 includes leading innovation in the post-wash segment, expanding the detergent portfolio across price tiers, and leveraging heritage brands in personal care to build a stronger category presence.
References
